Hyaluronan exacerbates renal fibrosis in NZB/W mice through increased MCP-1 and TGF-β1 secretion by mesangial cells

Thursday Poster: TH-PO572BACKGROUND: Lupus nephritis is characterized by the production of anti-dsDNA antibodies and immune-mediated renal injury leading to glomerular and tubulointerstitial fibrosis. We have previously demonstrated that circulating hyaluronan (HA) level and glomerular HA expression are increased in patients and lupus-prone mice with active lupus nephritis, and are associated with increased glomerular matrix protein accumulation. This study investigates the role of HA on disease manifestations and renal fibrogenesis in a murine model of lupus nephritis. METHODS: Pre-disease female NZB/W mice were randomized to receive sterile PBS or high molecular weight HA by tail-vein injection (1mg/ml, 200l) once weekly for periods up to 24 weeks, after which the mice were sacrificed, blood and urine collected, and kidneys harvested to assess renal histology and expression of fibrosis mediators. Mesangial cells were isolated from the renal cortex of NZB/W mice to investigate the mechanisms that mediate increased HA synthesis. RESULTS: Treatment of mice with HA had no effect on survival, proteinuria or antidsDNA antibody level compared to control mice, but was associated with increased glomerular IgG and C3 deposition, significantly increased glomerular and tubulointerstitial expression of HA receptor CD44, MCP-1, TGF- β1, fibronectin and collagen type I from 18 to 24 weeks. Exogenous HA for 24h had no effect on mesangial cell proliferation, but significantly increased CD44, HA synthase III, fibronectin, laminin and collagen synthesis, in part through the induction of MCP-1 and TGF- β1 secretion (P<0.01 for both). Stimulation of mesangial cells with exogenous MCP-1 and TGF-β1 significantly increased cell associated and secreted HA levels respectively (P